Biotech · Private company
BlueRock Therapeutics
Track this companyFree. Adds BlueRock Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials53 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- bemdaneprocelPhase 3 · Parkinsons Disease (PD)ClinicalTrials.gov · fetched Nov 12, 2026
- Sham surgeryPhase 3 · Parkinsons Disease (PD)ClinicalTrials.gov · fetched Nov 12, 2026
- OpCT-001Phase 2 · Primary Photoreceptor DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MSK-DA01Phase 1 · Advanced Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MSK-DA01 Cell Delivery DevicePhase 1 · Advanced Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePHASE3 · RECRUITING · started Jun 17, 2025ClinicalTrials.gov NCT06944522 · fetched Nov 12, 2026
- A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)PHASE1_PHASE2 · RECRUITING · started Mar 10, 2025ClinicalTrials.gov NCT06789445 · fetched Nov 12, 2026
- Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01ENROLLING_BY_INVITATION · started May 16, 2023ClinicalTrials.gov NCT05897957 · fetched Nov 12, 2026
- Noninterventional Study Evaluating Parkinson's Disease Diary UseUNKNOWN · started Jul 29, 2022ClinicalTrials.gov NCT05363046 · fetched Nov 12, 2026
- Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's DiseasePHASE1 · COMPLETED · started May 3, 2021ClinicalTrials.gov NCT04802733 · fetched Nov 12, 2026